Pharma Journalist -

Conatus Pharmaceuticals Inc. and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,…
Read More...

SMi Reports: Pain Therapeutics will return to London for its 20th consecutive year to explore the cutting-edge research of novel therapeutics SMi Group are pleased to announce the 20th…
Read More...

TILT Biotherapeutics announces that they have signed a license agreement with Biotheus Inc. (“Biotheus”), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the…
Read More...

Roche announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq (atezolizumab) in combination…
Read More...

Merck, known as MSD outside the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for…
Read More...

AbbVie and Allergan announced that Allergan has entered into definitive agreements to divest brazikumab (IL-23 inhibitor) and Zenpep (pancrelipase). These agreements are in conjunction…
Read More...

EyePoint Pharmaceuticals and Ocumension Therapeutics announced an exclusive license agreement for the development and commercialization of DEXYCU (dexamethasone intraocular suspension)…
Read More...

SMi Reports: On Day One, the main focus points for discussion will be on drug product formulation and control strategies. Sessions include: Challenges and opportunities in…
Read More...

Bionetix, a biotech company developing novel oncology drugs; ProQinase, an oncology-focused contract research organization (CRO) recently acquired by Reaction Biology Corporation…
Read More...

SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th of February 2020. This event provides the platform for industry experts from…
Read More...